date:Sep 17, 2012
Biotech company Enzymotec has reported that clinical trials for its lipid-based ingredient line for infant nutrition yielded positive results.
The company said that its strategy is to develop and market a line of products mimicking the vital lipids found in mother's milk, such as triglyceride, phospholipids and long-chain polyunsaturated fatty acids (LCPUFA).
According to Enzymotec, it will publish four new scientific articles on its lipid-based ingredients for infant nutrition in peer-review